Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FSLR vs MRNA✓SelectedUSD · MRNAFSLR vs MRNA performance historyLatest closeAs of-5.22%11/16
Stock and ETF performance explorer

FSLR vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+281.4%
MRNA return
+878.5%
Excess return
-597.1%
Maximum drawdown
-60.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-5.2%-3.6%-1.6%-5.0%
7D-15.2%-20.0%+4.8%-14.1%
30D-5.9%-1.3%-4.6%-6.0%
3M-28.0%+240.0%-268.0%-36.1%
6M-30.4%+339.0%-369.4%-40.1%
YTD-37.8%+630.0%-667.8%-49.6%
1Y-35.8%+769.1%-804.9%-48.9%
3Y+5.1%+181.2%-176.1%-8.8%
5Y+55.5%-8.1%+63.6%+40.7%
All+281.4%+878.5%-597.1%+247.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling